15 Jan, 2013Pharmaceutical Innovation: Structure and Alliances


“Pharmaceutical Innovation” is a broad term that can encompass and affect any step of the drug discovery and development process, so how exactly…

Read More

14 May, 2012Buying Innovation: A Look at Pharmaceutical Mergers and Acquisitions


We’ve looked at what happens to a drug when a patent expires, but what happens to the patent owner? As patents have expired and many blockbuster drugs become generic, pharmaceutical companies have looked to new drugs and innovations to replace the lost income. Getting a drug through regulatory hurdles, such as clinical trials and safety testing, is difficult and millions of dollars can be lost from an unexpected failure. As many patents have expired and only a few drugs have replaced them in the past decade, pharmaceutical companies have looked to mergers and acquisitions for new products and drugs in an effort to buy innovation.

Read More